Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Jun;52(6):999-1005.
doi: 10.1016/j.jpedsurg.2017.03.028. Epub 2017 Mar 18.

Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells

Affiliations
Comparative Study

Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells

Christopher J McCulloh et al. J Pediatr Surg. 2017 Jun.

Abstract

Purpose: Necrotizing enterocolitis (NEC) is a leading cause of gastrointestinal morbidity and mortality in premature infants. While studies have shown potential for stem cell (SC) therapy in experimental NEC, no study has compared different SC side-by-side. Our purpose was to determine whether one type of SC may more effectively treat NEC than others.

Methods: Four SC were compared: (1) amniotic fluid-derived mesenchymal SC (AF-MSC); (2) amniotic fluid-derived neural SC (AF-NSC); (3) bone marrow-derived mesenchymal SC (BM-MSC); and (4) neonatal enteric neural SC (E-NSC). Using an established rat model of NEC, pups delivered prematurely received an intraperitoneal injection of SC. Control pups were injected with PBS. Additional controls were breast-fed by surrogates and not subjected to experimental NEC. Intestinal tissue was graded histologically.

Results: NEC incidence was: PBS, 61.3%; breast-fed unstressed, 0%; AF-MSC, 19.1%; BM-MSC, 22.9%; AF-NSC, 18.9%; E-NSC 22.2%. All groups demonstrated statistical significance (p<0.05) compared to controls, and there was no difference between SC groups.

Conclusion: All four SC groups reduced the incidence and severity of experimental NEC equivalently. AF-MSC may be preferable because of availability of AF at delivery and ease of expansion, increasing potential for clinical translation.

Level of evidence: V (Animal study).

Keywords: Amniotic fluid; Mesenchymal; NEC; Necrotizing enterocolitis; Neural stem cells; Stem cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow cytometric analysis of stem cells
Red lines represent negative controls and blue lines represent populations of interest. (A) AF-MSC, positive for CD29, CD49e, CD90; partially positive for Oct4; negative for CD11 and CD45; (B) BM-MSC, positive for CD90 and negative for CD11 and CD45; (C) AF-NSC, positive for Nestin; (D) E-NSC, positive for Nestin.
Figure 2
Figure 2. Multipotency verification
AF-MSC and BM-MSC (passage 5) were induced along adipogenic and osteogenic differentiation pathways. Shown are representative images of (A) AF-MSC with lipid droplets staining positive with Oil Red O after 7d and (B) AF-MSC staining positive for calcium with Alizarin Red S after 14d. Similar findings were obtained for BM-MSC.
Figure 3
Figure 3. Representative images of histologic injury scores
Sections of small intestine were stained with H&E and graded as follows: (A) grade 0, normal intestine; (B) grade 1, epithelial cell lifting; (C) grade 2, necrosis to mid-villus; (D) grade 3, necrosis of entire villus; (E) grade 4, transmural necrosis. Magnification ×20.
Figure 4
Figure 4. Incidence and severity of NEC
With the exception of rat pups in the breastfed group, all other pups were subjected to experimental NEC. (A) Percentages of pups with histologic injury scores of 2, 3 or 4, consistent with histologic NEC. The white numbers within the colored sections of the bars represent the percent incidence of Grade 2, 3 or 4 NEC, and the bold numbers at the top of each bar represent the total incidence of NEC. (B) Percentages of pups with histologic injury scores of 3 or 4, consistent with severe NEC. The white numbers within the colored sections of the bars represent the percent incidence of Grade 3 or 4 NEC, and the bold numbers at the top of each bar represent the total incidence of severe NEC.

References

    1. Neu J, Walker WA. Necrotizing enterocolitis. The New England journal of medicine. 2011;364(3):255–64. Epub 2011/01/21. - PMC - PubMed
    1. Eaton S, Zani A, Pierro A, De Coppi P. Stem cells as a potential therapy for necrotizing enterocolitis. Expert opinion on biological therapy. 2013;13(12):1683–9. Epub 2013/10/25. - PubMed
    1. Zani A, Cananzi M, Lauriti G, Fascetti-Leon F, Wells J, Siow B, et al. Amniotic fluid stem cells prevent development of ascites in a neonatal rat model of necrotizing enterocolitis. European journal of pediatric surgery: official journal of Austrian Association of Pediatric Surgery [et al] = Zeitschrift fur Kinderchirurgie. 2014;24(1):57–60. Epub 2013/07/16. - PubMed
    1. Markel TA, Crisostomo PR, Lahm T, Novotny NM, Rescorla FJ, Tector J, et al. Stem cells as a potential future treatment of pediatric intestinal disorders. Journal of pediatric surgery. 2008;43(11):1953–63. Epub 2008/10/31. - PMC - PubMed
    1. Tayman C, Uckan D, Kilic E, Ulus AT, Tonbul A, Murat Hirfanoglu I, et al. Mesenchymal stem cell therapy in necrotizing enterocolitis: a rat study. Pediatric research. 2011;70(5):489–94. Epub 2011/07/21. - PubMed

Publication types